OTCMKTS:BPSR Organicell Regenerative Medicine (BPSR) Stock Price, News & Analysis → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free BPSR Stock Alerts $1.25 -0.16 (-11.35%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$1.25▼$1.3550-Day Range$1.35▼$3.4952-Week Range$0.04▼$0.63Volume811 shsAverage Volume3.31 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesInsider TradesSEC FilingsStock AnalysisChartFinancialsHeadlinesInsider TradesSEC Filings Get Organicell Regenerative Medicine alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Organicell Regenerative Medicine Stock (OTCMKTS:BPSR)Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.Read More BPSR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BPSR Stock News HeadlinesMarch 4, 2024 | finanznachrichten.deZEO ScientifiX, Inc.: Organicell Regenerative Medicine Rebranding to ZEO ScientifiXDecember 17, 2023 | uk.investing.comOrganicell Regenerative Medicine Inc (OCELD)April 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!December 2, 2023 | seekingalpha.comOCELD Organicell Regenerative Medicine, Inc.November 30, 2023 | benzinga.comOrganicell Regenerative Stock (OTC:OCEL) Dividends: History, Yield and DatesNovember 27, 2023 | finance.yahoo.comOrganicell Announces 1-for-200 Reverse Stock SplitJuly 28, 2023 | finanznachrichten.deOrganicell Regenerative Medicine, Inc.: Organicell Reports Interim Results of Phase 1/2A Research ProgramJuly 26, 2023 | finance.yahoo.comOrganicell Reports Interim Results of Phase 1/2A Research ProgramApril 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!June 29, 2023 | finanznachrichten.deOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOJune 29, 2023 | finance.yahoo.comOrganicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOJune 23, 2023 | finanznachrichten.deOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Harry Leider, MD, MBA as its New CEOJune 22, 2023 | marketwatch.com8-K: Organicell Regenerative Medicine, Inc.June 21, 2023 | finance.yahoo.comOrganicell Welcomes Harry Leider, MD, MBA as its New CEOMay 5, 2023 | marketwatch.comGlobal Regenerative Medicine Market [2023-2030] | Latest Trends and Insights | Market to Reach Worth USD 116410 MillionMay 4, 2023 | bbc.comCan regenerative wool make fashion more sustainable?April 6, 2023 | investing.comOrganicell Regenerative Medicine Inc (OCEL)April 5, 2023 | seekingalpha.comOCEL Organicell Regenerative Medicine, Inc.March 29, 2023 | marketwatch.comRegenerative Medicine Market Trends for Future Success 2023-2028March 29, 2023 | marketwatch.comRegenerative Medicine Market 2023: Growing Opportunities by 2028March 18, 2023 | finance.yahoo.comRegenerative Medicine Market Report 2023-2033February 22, 2023 | finance.yahoo.comMount Vernon, IN Regenerative Medicine Procedures Launched By NuYou TherapiesJanuary 17, 2023 | marketwatch.comRegenerative Medicine Market Regional Outlook & Size Projections with SWOT Analysis to Witness Rapid Growth 2026January 14, 2023 | finance.yahoo.comRegenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical AilmentsJanuary 14, 2023 | marketwatch.comRegenerative Medicine for Cartilage Market Industry Expansion Strategies till 2028 with SWOT & RISK AnalysisJanuary 14, 2023 | wsj.comOrganicell Regenerative Medicine Inc.January 11, 2023 | finance.yahoo.comThe Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic ConditionsSee More Headlines Receive BPSR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:BPSR CUSIPN/A CIK1557376 Webwww.bespoketricycles.com Phone(888) 963-7881FaxN/AEmployees18Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesAlbert MitraniPresident, CEO, COO, Secretary & TreasurerIan T. BothwellChief Financial Officer & DirectorMaria Ines MitraniDirector, Chief Science Officer & Vice PresidentGeorge Craig ShapiroDirector & Chief Medical OfficerKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors BPSR Stock Analysis - Frequently Asked Questions How have BPSR shares performed in 2024? Organicell Regenerative Medicine's stock was trading at $1.02 on January 1st, 2024. Since then, BPSR shares have increased by 22.5% and is now trading at $1.25. View the best growth stocks for 2024 here. What other stocks do shareholders of Organicell Regenerative Medicine own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organicell Regenerative Medicine investors own include Ciena (CIEN), Orbit Garant Drilling (OGD), Royal Caribbean Cruises (RCL), Synergy Pharmaceuticals (SGYP), Achillion Pharmaceuticals (ACHN), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS) and Abacus Property Group (ABP). How do I buy shares of Organicell Regenerative Medicine? Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BPSR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organicell Regenerative Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
